Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and gabaergic drugs
Short Communication
Received:
- 144 Downloads
- 14 Citations
Summary
A case of post-anoxic action myoclonus is reported in which a very good control of the myoclonic jerks was achieved with levodopa, gaba and bacoflen, while the antiepileptic drugs did not seem to be useful.
Key words
Post-anoxic action myoclonus Lance-Adams syndrome Levodopa Gaba Bacoflen Antiepileptic drugsZusammenfassung
Beschrieben wird ein Fall von postanoxicher Myoklonie, der durch L-Dopa, Gaba und Bacoflen fast völlig unter Kontrolle gebracht werden konnte. Antiepileptische Medikamente scheinen nicht wirksam zu sein.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Boudouresques, J., Roger, J., Khalil, R., Vigouroux, R. A., Gosset, A., Pellissier, J. F., Tassinari, C. A.: A propos de 2 observations de syndrome de Lance et Adams. Effet therapeutique du RO-05-4023. Revue Neurol. 125, 306–309 (1971)Google Scholar
- 2.Castaigne, P., Cambier, J., Escourolle, R., Cathala, H. P., Lecasble, R.: Observation anatomo-clinique d'un syndrome myoclonique post-anoxique. Revue Neurol. 111, 60–73 (1964)Google Scholar
- 3.Castaigne, P., Cambier, J., Escourolle, R.: Les myoclonies d'intention et d'action. Revue Neurol. 111, 107–120 (1968)Google Scholar
- 4.Cartlidge, F., Hudgson, P., Weightman, D.: A comparation of bacoflen and diazepam in the treatment of spasticity. J. Neurol. Sci. 23, 17–24 (1974)Google Scholar
- 5.Chadwick, D., Hallet, M., Harris, R., Jenner, P., Reynolds, E. H., Marsden, C. D.: Manipulation of brain serotonin in the treatment of myoclonus. Lancet 1975 II, 424–425Google Scholar
- 6.Chadwick, D., Hallet, M., Harris, R., Jenner, P., Reynolds, E. H., Marsden, C. D.: Clinical, biochemical and physiological features distinguishing myoclonus responsive to 5-hidroxytryptophan, triptophan with a monoamine oxidase inhibitor and clonazepam. Brain 100, 455–487 (1977)Google Scholar
- 7.Davidoff, R. A., Sears, E. S.: The effects of Lioresal on synaptic activity in the isolated spinal cord. Neurology (Minneap) 24, 957–963 (1974)Google Scholar
- 8.De Lean, J.: Action myoclonus and serotoninergic activity. N. Engl. J. Med. 296, 24, 1414–1415 (1977)Google Scholar
- 9.Goldberg, M. A., Dorman, J. D.: Intention myoclonus: successful treatment with clonazepam. Neurology (Minneap) 26, 24–26 (1976)Google Scholar
- 10.Lance, J. W., Adams, R. D.: The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopaty. Brain 86, 111–136 (1963)Google Scholar
- 11.Lhermitte, F., Talairach, J., Buser, P., Gautier, J. C., Bancaud, J., Gras, R., Truelle, J. L.: Myoclonies d'intention et d'action post-anoxiques. Etude stereotaxique et descruction du noyau ventral lateral du thalamus. Revue Neurol. 124, 5–20 (1971)Google Scholar
- 12.Lhermitte, F., Marteau, R., Degos, C. F.: Analyse pharmacologique d'un noveau cas de myoclonies d'intention et d'action post-anoxiques. Revue Neurol. 126, 107–114 (1972)Google Scholar
- 13.Minoli, G., Tredici, G.: Levodopa in treatment of myoclonus. Lancet 1974 II, 472Google Scholar
- 14.Rollinson, R. D., Gilligan, B. S.: Post-anoxic action myoclonus (Lance Adams Syndrome) responding to valproate. Arch. Neurol. 36, 44–45 (1979)Google Scholar
- 15.Sherwin, I., Redmon, W.: Successful treatment in action myoclonus. Neurology (Minneap) 19, 846–850 (1969)Google Scholar
- 16.Van Woert, M. H., Sethy, V. H.: Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxilase inhibitor, MK 486. Neurology (Minneap) 25, 135–140 (1975)Google Scholar
Copyright information
© Springer-Verlag 1980